{"id":456873,"date":"2021-03-12T10:03:35","date_gmt":"2021-03-12T15:03:35","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=456873"},"modified":"2021-03-12T10:03:35","modified_gmt":"2021-03-12T15:03:35","slug":"aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/","title":{"rendered":"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology"},"content":{"rendered":"
\n

Dr. Frieman Discusses Development of Pan-Viral Drugs with AIkido<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n NEW YORK<\/span>, March 12, 2021<\/span> \/PRNewswire\/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Matt Frieman<\/span> appeared on the video podcast This Week in Virology, segment entitled “TWiV 729: A floret of spikes with Matt Frieman<\/span><\/a>.”\u00a0 In the video, Dr. Frieman discusses the Covid-19\u00a0pandemic from the point of view of a coronavirologist.\u00a0 <\/p>\n

\n

\n
\n \"(PRNewsfoto\/AIkido
\n <\/a>\n <\/p>\n<\/p><\/div>\n

The entire video can be seen here: https:\/\/www.microbe.tv\/twiv\/<\/a><\/p>\n

At the forty-two minute mark, Dr. Frieman discusses the future of this type of virology work and his work on the pan-viral initiative with AIkido Pharma.\u00a0 The Company is proud to be working with industry leaders like Dr. Frieman in the development of a family of pan-viral drugs.<\/p>\n

\n About AIkido Pharma Inc.
<\/b>AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics.\u00a0 The Company’s platform consists of patented technology from leading universities and researchers and we are currently in the process of developing an innovative therapeutic drug platform through strong partnerships with world renowned educational institutions, including The\u00a0University of Texas<\/span> at Austin\u00a0and\u00a0Wake Forest University. Our diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, we are constantly seeking to grow our pipeline to treat unmet medical needs in oncology.\u00a0 The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus.<\/p>\n

\n Forward-Looking Statements
<\/b>Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the SEC, not limited to Risk Factors relating to its business contained therein. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Contact:<\/b>\n <\/p>\n

Investor Relations:
Hayden IR
Brett Maas<\/span>, Managing Partner
Phone: (646) 536-7331
Email: brett@haydenir.com<\/a>
www.haydenir.com<\/a><\/p>\n

AIkido Pharma Inc.:
Phone: 212-745-1373
Email: info@aikidopharma.com<\/a>
www.aikidopharma.com<\/a><\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology-301246460.html<\/a><\/p>\n

SOURCE AIkido Pharma Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Dr. Frieman Discusses Development of Pan-Viral Drugs with AIkido PR Newswire NEW YORK, March 12, 2021 \/PRNewswire\/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment entitled “TWiV 729: A floret of spikes with Matt Frieman.”\u00a0 In the video, Dr. Frieman discusses the Covid-19\u00a0pandemic from the point of view of a coronavirologist.\u00a0 The entire video can be seen here: https:\/\/www.microbe.tv\/twiv\/ At the forty-two minute mark, Dr. Frieman discusses the future of this type of virology work and his work on the pan-viral initiative with AIkido Pharma.\u00a0 The Company is proud to be working with industry leaders like Dr. Frieman in the development of … <\/p>\n

Continue reading “AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-456873","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Frieman Discusses Development of Pan-Viral Drugs with AIkido PR Newswire NEW YORK, March 12, 2021 \/PRNewswire\/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment entitled “TWiV 729: A floret of spikes with Matt Frieman.”\u00a0 In the video, Dr. Frieman discusses the Covid-19\u00a0pandemic from the point of view of a coronavirologist.\u00a0 The entire video can be seen here: https:\/\/www.microbe.tv\/twiv\/ At the forty-two minute mark, Dr. Frieman discusses the future of this type of virology work and his work on the pan-viral initiative with AIkido Pharma.\u00a0 The Company is proud to be working with industry leaders like Dr. Frieman in the development of … Continue reading "AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T15:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology\",\"datePublished\":\"2021-03-12T15:03:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/\"},\"wordCount\":478,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/\",\"name\":\"AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"datePublished\":\"2021-03-12T15:03:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1138079\\\/Aikida_Pharma_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/","og_locale":"en_US","og_type":"article","og_title":"AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk","og_description":"Dr. Frieman Discusses Development of Pan-Viral Drugs with AIkido PR Newswire NEW YORK, March 12, 2021 \/PRNewswire\/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Matt Frieman appeared on the video podcast This Week in Virology, segment entitled “TWiV 729: A floret of spikes with Matt Frieman.”\u00a0 In the video, Dr. Frieman discusses the Covid-19\u00a0pandemic from the point of view of a coronavirologist.\u00a0 The entire video can be seen here: https:\/\/www.microbe.tv\/twiv\/ At the forty-two minute mark, Dr. Frieman discusses the future of this type of virology work and his work on the pan-viral initiative with AIkido Pharma.\u00a0 The Company is proud to be working with industry leaders like Dr. Frieman in the development of … Continue reading \"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-12T15:03:35+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology","datePublished":"2021-03-12T15:03:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/"},"wordCount":478,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/","name":"AIkido Pharma Announces Dr. Matt Frieman's Appearance on This Week in Virology - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","datePublished":"2021-03-12T15:03:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1138079\/Aikida_Pharma_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aikido-pharma-announces-dr-matt-friemans-appearance-on-this-week-in-virology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AIkido Pharma Announces Dr. Matt Frieman’s Appearance on This Week in Virology"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=456873"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/456873\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=456873"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=456873"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=456873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}